bioAffinity Technologies, Inc. (BIAF) has a negative trailing P/E of -0.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -256.29%.
Criteria proven by this page:
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2019 | -18.5 | 0.00 | -15.17 | 0.00 | - |
| 2020 | -8.4 | -0.07 | -4.06 | 0.00 | - |
| 2021 | -3.5 | -0.03 | -1.41 | 0.00 | - |
| 2022 | -0.9 | 0.04 | 0.65 | 1,498.73 | - |
| 2023 | -1.6 | 0.03 | 2.65 | 5.08 | - |
| 2024 | -1.2 | 0.07 | 4.24 | 1.18 | - |
| 2025 | -0.1 | 0.00 | 0.28 | 0.33 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2019 | $-0.45 | $0.00 | $-3.31M | - |
| 2020 | $-0.99 | $0.00 | $-7.27M | - |
| 2021 | $-0.86 | $0.00 | $-6.33M | - |
| 2022 | $-1.81 | $4.8K | $-8.15M | -169768.9% |
| 2023 | $-0.91 | $2.53M | $-7.94M | -313.5% |
| 2024 | $-0.73 | $9.36M | $-9.04M | -96.6% |
| 2025 | $-8.66 | $6.16M | $-14.91M | -242% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-8.10 | $-8.10 – $-8.10 | $7.31M | $7.31M – $7.31M | 1 |
